Intrapartum Monitoring Devices Market
According to Pharmanucleus’s newly published report, the global “Intrapartum Monitoring Devices Market” is predicted to grow at a tremendous CAGR of 7 % during the forecast period 2023-2030.
The market for medical devices used to monitor fetal and maternal well-being during delivery is the Intrapartum Monitoring Devices Market. These gadgets are used to monitor the birth process's progress and detect any difficulties that may emerge throughout the procedure.
Electronic fetal monitors, maternal vital sign monitors, and uterine contraction monitors are common intrapartum monitoring technologies. Electronic fetal monitors track the baby's heart rate and responsiveness to contractions. Maternal vital sign monitors record the mother's blood pressure, heart rate, and other vital signs, whereas uterine contraction monitors to track the frequency and strength of contractions.
Market Drivers:
The usage of intrapartum monitoring devices is expected to grow because of the great potential for technology adoption in developing countries caused by a rise in fetal health monitoring practices and an increase in birth problems.
Furthermore, there is an increased demand for enhanced medical technology, governments are making significant expenditures to improve fetal health monitoring, and biotechnological firms are becoming more established in emerging nations. These reasons lead to developing nations' tremendous expansion in the healthcare industry.
Furthermore, the cost-effectiveness of intrapartum monitoring devices is expected to drive market development. The growing use of fetal monitoring devices as a safety measure for their kid and increased awareness of the risks connected with birth disorders has increased demand for monitoring systems.
Growth Factors:
Intrapartum monitoring devices provide significant clinical advantages.
The need for intrapartum monitoring devices has grown due to the growing need for better maternal healthcare and the rising incidence of complications associated with preterm birth. Healthcare spending is increasing in developing nations, and people are becoming more aware of the benefits of monitoring devices, providing market participants with greater chances.
The market is expanding due to increased dangers and issues such as brain damage, cerebral palsy, newborn convulsions, and fetal death during childbirth.
Increased usage of infertility therapies and rising incidence of preterm delivery
Numerous studies have found high blood pressure, prolonged pre-labor membrane rupturing, antepartum hemorrhage, multiple gestations, urinary tract infections (UTIs), short cervixes, assisted reproductive technology, and placenta previa are all contributing to the rise in preterm births.
Furthermore, due to the increasing frequency of preterm deliveries, current medical technology has been included in fetal monitoring systems.
Restraints:
The exorbitant expense of these devices and growing concerns about monitoring radiation influencing patients' health are proving to be significant impediments to industry expansion. A scarcity of skilled obstetricians in developing countries further hampers the market's development. Furthermore, many individuals in undeveloped and impoverished countries are unaware that such technologies are available. Furthermore, more women give birth at home in these countries, lowering the need for monitoring systems in hospitals and clinics.
Geographical Analysis:
Geographically, the largest market for intrapartum monitoring devices is in North America, Europe, and Asia Pacific. The market is predicted to increase significantly in emerging economies such as China, India, and Brazil due to rising demand for healthcare services and a renewed focus on maternal and child health.
Opportunities in Intrapartum monitoring devices:
The increasing deployment of fetal monitoring devices is one of the market's significant potential. Fetal monitoring is a critical component of intrapartum care, and the rising incidence of high-risk pregnancies is driving demand for improved fetal monitoring technologies. Furthermore, increased demand for non-invasive and wireless fetal monitoring technologies will open new avenues for market participants.?
The growing demand for point-of-care testing (POCT) devices is another significant potential for the intrapartum monitoring devices industry. POCT devices are used at the bedside to diagnose and monitor various health issues and deliver quick and reliable test findings. The growing requirement for speedy and accurate diagnosis during delivery is projected to drive up demand for POCT devices.
Market Challenges:
Despite the potential, the market for intrapartum monitoring devices confronts significant hurdles. The expensive cost of these gadgets is one of the primary problems. The expense of intrapartum monitoring equipment is frequently out of reach for most individuals in many impoverished nations. Another problem the business faces is a shortage of qualified healthcare personnel to operate and understand the data supplied by these devices.
Competitive Landscape:
Key players operating in the Intrapartum monitoring devices market include
-
GE Healthcare
-
Koninklijke Philips N.V.
-
Siemens Healthineers.
-
FUJIFILM SonoSite, Inc.
-
Huntleigh Healthcare Limited.
-
Spacelabs Healthcare, Inc.
-
Edan Instruments, Inc.
-
Neoventa Medical AB.
-
Medtronic plc, and Natus Medical Incorporated.
Segmentation Analysis:
The global Intrapartum Monitoring Devices Market is segmented by product type, method, and, end-user
By Product Type:
-
Monitors
-
Electrodes
By Method:
-
Non-Invasive
-
Invasive
By End User:
-
Hospitals
-
Maternity Centers
-
Others
Method Insights:
The invasive category accounted for a sizable revenue share in the intrapartum monitoring devices market. The increased efficacy and dependability of intrusive procedures are responsible for the segment's expansion. Using invasive internal monitoring yields the greatest registration quality. In the intrusive mode, monitoring instruments such as fetal electrocardiograms (ECGs) are directly recorded from the scalp of a fetus. The membranes must be ruptured to insert electrodes through the cervix and put on the fetus's scalp during an invasive fetal electrocardiogram (ECG).
End-user Insights:
In the intrapartum monitoring devices market, hospitals had the highest revenue share. The population's preference for intrapartum surveillance in hospitals and the convenience with which patients may now attend hospitals and clinics following the COVID-19 epidemic is driving growth. The hospital's clean and sanitary atmosphere reduces the likelihood of contracting an illness. Furthermore, in many impoverished countries, most intrapartum monitoring technologies are only available in hospital settings.
Key Developments:
-
CooperSurgical announced the purchase of Safe Obstetric Systems, the creator of the patented single-use product, the Fetal Pillow®, in March 2021. The Fetal Pillow protects a profoundly affected fetal head during a dilated C-section. (CSFD). With rising maternal morbidity and mortality rates, there is a greater emphasis on decreasing maternal and fetal difficulties during delivery. Using the Fetal Pillow in technically hard clinical circumstances such as CSFD may minimize maternal blood transfusion.
-
In April 2022, Royal Philips signed a strategic collaboration deal with Oulu University Hospital (Finland) to assist the hospital's ambitious OYS2030 modernization program. The program intends to modernize Oulu University Hospital's operations and infrastructure to meet the requirements of future specialized care. Philips offers the most recent image-guided therapy solutions and technologies to help revolutionize patient diagnosis and treatment and maintenance, consulting, and financing services.
About us:
Pharmanucleus is a market research firm that offers clients access to custom and syndicated reports and consultancy on a single platform as a corporation with an extensive understanding of healthcare fields such as pharmaceuticals, medical devices, and biotechnology. Pharmanucleus insights assist life sciences and other healthcare organizations in accelerating the introduction, development, and distribution of life-saving medications, navigate significant attention from essential opinion leaders, and ensuring fair access to healthcare services. We deliver healthcare insights that discover the most recent market research data, which sets us apart from the competition. Our unparalleled coverage provides decision-makers with the confidence to tackle the future of the world's most diverse sectors. Pharmanucleus assists hundreds of firms in bringing their products or services to market early by providing a complete perspective of the sector with statistical estimates. This panoramic view helps customers understand their industry more completely and faster, allowing them to make strategic decisions ahead of their competition.